Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Blohmke, CJ"'
Autor:
Salerno-Gonçalves, R, Fresnay, S, Magder, L, Darton, TC, Waddington, CS, Blohmke, CJ, Angus, B, Levine, MM, Pollard, AJ, Sztein, MB
Publikováno v:
Cellular immunology. 378
We have previously demonstrated that Mucosal-Associated Invariant T (MAIT) cells secrete multiple cytokines after exposure to Salmonella enterica serovar Typhi (S. Typhi), the causative agent of typhoid fever in humans. However, whether cytokine secr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa16432500dc6614316c4da169a6dbbe
https://pubmed.ncbi.nlm.nih.gov/35772315
https://pubmed.ncbi.nlm.nih.gov/35772315
Autor:
Booth JS; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.; Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, United States., Rapaka RR; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United States., McArthur MA; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.; Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, United States.; Global Clinical Development, Sanofi, Swiftwater, PA, United States., Fresnay S; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.; Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, United States.; Rockville Center for Vaccine Research, GlaxsoSmithKline (GSK), Rockville, MD, United States., Darton TC; Oxford Vaccine Group, Department of Pediatrics, University of Oxford, and the National Institute for Health and Care Research (NIHR), Oxford Biomedical Research Centre, Oxford, United Kingdom.; Clinical Infection Research Group, Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, and the National Institute for Health and Care Research (NIHR), Sheffield Biomedical Research Centre, Sheffield, United Kingdom., Blohmke CJ; Oxford Vaccine Group, Department of Pediatrics, University of Oxford, and the National Institute for Health and Care Research (NIHR), Oxford Biomedical Research Centre, Oxford, United Kingdom.; GlaxsoSmithKline (GSK) Vaccines, London, United Kingdom., Jones C; Oxford Vaccine Group, Department of Pediatrics, University of Oxford, and the National Institute for Health and Care Research (NIHR), Oxford Biomedical Research Centre, Oxford, United Kingdom., Waddington CS; Oxford Vaccine Group, Department of Pediatrics, University of Oxford, and the National Institute for Health and Care Research (NIHR), Oxford Biomedical Research Centre, Oxford, United Kingdom.; Department of Infection, Imperial College Healthcare, National Health Service (NHS) Trust, London, United Kingdom.; Department of Medicine, Imperial College London, London, United Kingdom., Levine MM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.; Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, United States.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United States., Pollard AJ; Oxford Vaccine Group, Department of Pediatrics, University of Oxford, and the National Institute for Health and Care Research (NIHR), Oxford Biomedical Research Centre, Oxford, United Kingdom., Sztein MB; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States.; Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, United States.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United States.; Tumor Immunology and Immunotherapy Program, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Sep 12; Vol. 15, pp. 1384642. Date of Electronic Publication: 2024 Sep 12 (Print Publication: 2024).
Autor:
Barton A; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre , Oxford, United Kingdom., Hill J; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre , Oxford, United Kingdom., O'Connor D; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre , Oxford, United Kingdom., Jones C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre , Oxford, United Kingdom., Jones E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre , Oxford, United Kingdom., Camara S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre , Oxford, United Kingdom., Shrestha S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre , Oxford, United Kingdom., Jin C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre , Oxford, United Kingdom.; Department of Pathology, Royal Melbourne Hospital , Melbourne, Australia.; Infectious Diseases and Immune Defence Division, Walter and Eliza Hall Institute of Medical Research , Melbourne, Australia., Gibani MM; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre , Oxford, United Kingdom.; Department of Infectious Disease, Imperial College , London, United Kingdom., Dobinson HC; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre , Oxford, United Kingdom., Waddington C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre , Oxford, United Kingdom.; Department of Infectious Disease, Imperial College , London, United Kingdom., Darton TC; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre , Oxford, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease and The Florey Institute for Host-Pathogen Interactions, University of Sheffield , Sheffield, United Kingdom., Blohmke CJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre , Oxford, United Kingdom., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre , Oxford, United Kingdom.
Publikováno v:
Infection and immunity [Infect Immun] 2023 Oct 17; Vol. 91 (10), pp. e0010823. Date of Electronic Publication: 2023 Sep 19.
Autor:
Zhu H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; NIHR Oxford Biomedical Research Centre and Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Chelysheva I; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; NIHR Oxford Biomedical Research Centre and Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Cross DL; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; NIHR Oxford Biomedical Research Centre and Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Blackwell L; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; NIHR Oxford Biomedical Research Centre and Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Jin C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; NIHR Oxford Biomedical Research Centre and Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Gibani MM; Department of Infectious Disease, Imperial College London, St Mary's Campus, London, United Kingdom., Jones E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; NIHR Oxford Biomedical Research Centre and Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Hill J; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; NIHR Oxford Biomedical Research Centre and Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Trück J; Division of Immunology, University Children's Hospital Zurich, Zurich, Switzerland., Kelly DF; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; NIHR Oxford Biomedical Research Centre and Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Blohmke CJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; NIHR Oxford Biomedical Research Centre and Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; NIHR Oxford Biomedical Research Centre and Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., O'Connor D; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; NIHR Oxford Biomedical Research Centre and Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2023 Aug 15; Vol. 133 (16). Date of Electronic Publication: 2023 Aug 15.
Autor:
Siena E; GSK, Via Fiorentina 1, 53100 Siena, Italy. Electronic address: emilio.x.siena@gsk.com., Schiavetti F; GSK, Via Fiorentina 1, 53100 Siena, Italy. Electronic address: francesca.x.schiavetti@gsk.com., Borgogni E; GSK, Via Fiorentina 1, 53100 Siena, Italy. Electronic address: erica.x.borgogni@gsk.com., Taccone M; GSK, Via Fiorentina 1, 53100 Siena, Italy. Electronic address: marianna.x.taccone@gsk.com., Faenzi E; GSK, Via Fiorentina 1, 53100 Siena, Italy. Electronic address: elisa.x.faenzi@gsk.com., Brazzoli M; GSK, Via Fiorentina 1, 53100 Siena, Italy. Electronic address: michela.x.brazzoli@gsk.com., Aprea S; GSK, Via Fiorentina 1, 53100 Siena, Italy. Electronic address: susanna.x.aprea@gsk.com., Bardelli M; GSK, Via Fiorentina 1, 53100 Siena, Italy. Electronic address: monia.x.bardelli@gsk.com., Volpini G; GSK, Via Fiorentina 1, 53100 Siena, Italy. Electronic address: gifox1960@yahoo.it., Buricchi F; GSK, Via Fiorentina 1, 53100 Siena, Italy. Electronic address: francesca.x.buricchi@gsk.com., Sammicheli C; GSK, Via Fiorentina 1, 53100 Siena, Italy. Electronic address: chiara.x.sammicheli@gsk.com., Tavarini S; GSK, Via Fiorentina 1, 53100 Siena, Italy. Electronic address: simona.x.tavarini@gsk.com., Bechtold V; GSK, Rue de l'Institut 89, 1330 Rixensart, Belgium. Electronic address: viviane.x.bechtold@gsk.com., Blohmke CJ; GSK, Via Fiorentina 1, 53100 Siena, Italy. Electronic address: christoph.j.blohmke@gsk.com., Cardamone D; Toscana Life Sciences Foundation, Siena, Italy. Electronic address: d.cardamone@toscanalifesciences.org., De Intinis C; GSK, Via Fiorentina 1, 53100 Siena, Italy; University of Turin, Via Verdi 8, 10124 Torino, Italy. Electronic address: carlo.deintinis@gmail.com., Gonzalez-Lopez A; GSK, 14200 Shady Grove Rd, Rockville MD, USA. Electronic address: antoniogonzalezlopez17@gmail.com., O'Hagan DT; University of Turin, Via Verdi 8, 10124 Torino, Italy. Electronic address: hagan@gsk.com., Nuti S; GSK, 14200 Shady Grove Rd, Rockville MD, USA. Electronic address: sandra.x.nuti@gsk.com., Seidl C; GSK, 14200 Shady Grove Rd, Rockville MD, USA. Electronic address: claudia.x.seidl@gsk.com., Didierlaurent AM; GSK, Rue de l'Institut 89, 1330 Rixensart, Belgium. Electronic address: arnaud.didierlaurent@unige.ch., Bertholet S; GSK, 14200 Shady Grove Rd, Rockville MD, USA. Electronic address: sylvie.c.bertholet-girardin@gsk.com., D'Oro U; GSK, Via Fiorentina 1, 53100 Siena, Italy. Electronic address: ugo.x.doro@gsk.com., Medini D; Toscana Life Sciences Foundation, Siena, Italy. Electronic address: d.medini@toscanalifesciences.org., Finco O; GSK, Via Fiorentina 1, 53100 Siena, Italy. Electronic address: oretta.x.finco@gsk.com.
Publikováno v:
Vaccine [Vaccine] 2023 Jan 16; Vol. 41 (3), pp. 724-734. Date of Electronic Publication: 2022 Dec 21.
Autor:
Barton A; Oxford Vaccine Group, Department of Paediatrics, University of Oxfordgrid.4991.5 and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom.; Clinical Research Department, London School of Hygiene and Tropical Medicine, London, United Kingdom., Hill J; Oxford Vaccine Group, Department of Paediatrics, University of Oxfordgrid.4991.5 and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom., Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxfordgrid.4991.5 and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom., Chen L; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxfordgrid.4991.5, Oxford, United Kingdom., Jones C; Oxford Vaccine Group, Department of Paediatrics, University of Oxfordgrid.4991.5 and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom., Jones E; Oxford Vaccine Group, Department of Paediatrics, University of Oxfordgrid.4991.5 and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom., Camara S; Oxford Vaccine Group, Department of Paediatrics, University of Oxfordgrid.4991.5 and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom., Shrestha S; Oxford Vaccine Group, Department of Paediatrics, University of Oxfordgrid.4991.5 and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom., Jin C; Oxford Vaccine Group, Department of Paediatrics, University of Oxfordgrid.4991.5 and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom., Gibani MM; Oxford Vaccine Group, Department of Paediatrics, University of Oxfordgrid.4991.5 and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom.; Department of Infectious Disease, Imperial College London, London, United Kingdom., Dobinson H; Oxford Vaccine Group, Department of Paediatrics, University of Oxfordgrid.4991.5 and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom., Waddington C; Oxford Vaccine Group, Department of Paediatrics, University of Oxfordgrid.4991.5 and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom.; Department of Medicine, University of Cambridge, Cambridge, United Kingdom., Darton TC; Oxford Vaccine Group, Department of Paediatrics, University of Oxfordgrid.4991.5 and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.; Florey Institute for Host-Pathogen Interactions, University of Sheffield, Sheffield, United Kingdom., Blohmke CJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxfordgrid.4991.5 and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxfordgrid.4991.5 and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom.
Publikováno v:
Infection and immunity [Infect Immun] 2022 Apr 21; Vol. 90 (4), pp. e0038921. Date of Electronic Publication: 2022 Mar 07.
Autor:
Tondi S; GlaxoSmithKline (GSK), Preclinical Evidence Generation (PEG), Siena, Italy.; Department of Life Sciences, University of Siena, Siena, Italy., Clemente B; GlaxoSmithKline (GSK), Preclinical Evidence Generation (PEG), Siena, Italy., Esposito C; GlaxoSmithKline (GSK), Preclinical Evidence Generation (PEG), Siena, Italy., Sammicheli C; GlaxoSmithKline (GSK), Preclinical Evidence Generation (PEG), Siena, Italy., Tavarini S; GlaxoSmithKline (GSK), Preclinical Evidence Generation (PEG), Siena, Italy., Martin LB; GlaxoSmithKline (GSK) Vaccines Institute for Global Health S.R.L. (GVGH), Siena, Italy., Rossi O; GlaxoSmithKline (GSK) Vaccines Institute for Global Health S.R.L. (GVGH), Siena, Italy., Micoli F; GlaxoSmithKline (GSK) Vaccines Institute for Global Health S.R.L. (GVGH), Siena, Italy., Bartolini E; GlaxoSmithKline (GSK), Preclinical Evidence Generation (PEG), Siena, Italy., Brazzoli M; GlaxoSmithKline (GSK), Preclinical Evidence Generation (PEG), Siena, Italy., Ulivieri C; Department of Life Sciences, University of Siena, Siena, Italy., Blohmke CJ; GlaxoSmithKline (GSK), Artificial Intelligence & Machine Learning (AIML), London, United Kingdom., Schiavetti F; GlaxoSmithKline (GSK), Preclinical Evidence Generation (PEG), Siena, Italy.
Publikováno v:
Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2022 Feb 03; Vol. 12, pp. 767153. Date of Electronic Publication: 2022 Feb 03 (Print Publication: 2022).
Autor:
Budroni S; GSK, Siena, Italy., Buricchi F; GSK, Siena, Italy., Cavallone A; GSK, Siena, Italy., Volpini G; GSK, Siena, Italy., Mariani A; GSK, Siena, Italy., Lo Surdo P; GSK, Siena, Italy., Blohmke CJ; GSK, Siena, Italy., Del Giudice G; GSK, Siena, Italy., Medini D; GSK, Siena, Italy., Finco O; GSK, Siena, Italy.
Publikováno v:
Computational and structural biotechnology journal [Comput Struct Biotechnol J] 2021 Jun 17; Vol. 19, pp. 3664-3672. Date of Electronic Publication: 2021 Jun 17 (Print Publication: 2021).
Autor:
Cross DL; The Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom., Verheul MK; The Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom., Leipold MD; The Human Immune Monitoring Center, Institute for Immunity, Transplantation and Infection, Stanford School of Medicine, Stanford, CA, United States., Obermoser G; The Human Immune Monitoring Center, Institute for Immunity, Transplantation and Infection, Stanford School of Medicine, Stanford, CA, United States., Jin C; The Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom., Jones E; The Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom., Starr JS; The Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom., Mohorianu I; The Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom., Blohmke CJ; The Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom., Maecker HT; The Human Immune Monitoring Center, Institute for Immunity, Transplantation and Infection, Stanford School of Medicine, Stanford, CA, United States., Napolitani G; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom., Hill J; The Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom., Pollard AJ; The Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom.
Publikováno v:
Frontiers in immunology [Front Immunol] 2020 Dec 03; Vol. 11, pp. 574057. Date of Electronic Publication: 2020 Dec 03 (Print Publication: 2020).
Autor:
Gibani MM; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom.; Department of Infectious Diseases, Imperial College London, United Kingdom., Jin C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom., Shrestha S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom., Moore M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom., Norman L; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom., Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom., Jones E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom., Blackwell L; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom., Thomaides-Brears H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom., Hill J; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom., Blohmke CJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom., Dobinson HC; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom., Baker P; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom., Jones C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom., Campbell D; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom., Mujadidi YF; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom., Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom., Preciado-Llanes L; Institute for Infection and Global Health, University of Liverpool, United Kingdom.; Medical Research Council Human Immunology Unit, Radcliffe Department of Medicine, University of Oxford, United Kingdom., Napolitani G; Medical Research Council Human Immunology Unit, Radcliffe Department of Medicine, University of Oxford, United Kingdom., Simmons A; Medical Research Council Human Immunology Unit, Radcliffe Department of Medicine, University of Oxford, United Kingdom., Gordon MA; Institute for Infection and Global Health, University of Liverpool, United Kingdom.; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi., Angus B; Nuffield Department of Medicine, University of Oxford, United Kingdom., Darton TC; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom., Cerundulo V; Medical Research Council Human Immunology Unit, Radcliffe Department of Medicine, University of Oxford, United Kingdom., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, United Kingdom.
Publikováno v:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2020 Oct 20; Vol. 14 (10), pp. e0008783. Date of Electronic Publication: 2020 Oct 20 (Print Publication: 2020).